IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Atlas Venture Life Science Advisors, LLC

Q3 2024 Holdings

Filed 2024-11-13 | 14 holdings | $1.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Dyne Therapeutics, Inc.(DYN)Common Stock26818M108$288.1M8,020,13626.7%
Kymera Therapeutics, Inc.(KYMR)Common Stock501575104$231.7M4,896,46221.5%
Third Harmonic Bio, Inc.(THRD)Common Stock88427A107$147.8M10,907,85913.7%
Disc Medicine, Inc.(IRON)Common Stock254604101$123.3M2,509,45611.4%
Q32 Bio, Inc.(QTTB)Common Stock746964105$93.3M2,092,1068.7%
Day One Biopharmaceuticals, Inc.(DAWN)Common Stock23954D109$89.6M6,430,2578.3%
Korro Bio, Inc.(KRRO)Common Stock500946108$38.0M1,137,1493.5%
Generation Bio, Co.(GBIOGBX)Common Stock37148K100$20.5M8,279,4841.9%
Vigil Neuroscience, Inc.(VIGL)Common Stock92673K108$19.8M5,836,8741.8%
Tectonic Therapeutics, Inc.(TECX)Common Stock878972108$11.5M378,4471.1%
Ikena Oncology, Inc.Common Stock45175G108$8.7M5,018,1780.8%
Aerovate Therapeutics, Inc.Common Stock008064107$3.8M1,799,2320.3%
Dianthus Therapeutics, Inc.(DNTH)Common Stock252828108$2.1M76,9790.2%
Spero Therapeutics, Inc.(SPRO)Common Stock84833T103$539.9K402,8850.1%